A major discovery in cancer investigation is arising with the use of mini-antibodies to re-engage mutated p53. This vital cancer inhibitor protein is frequently lost in several forms of tumors, leading uncontrolled https://free-bookmarking.com/story22028025/mini-antibodies-reactivate-the-p53-protein-the-new-approach-for-malignant-treatment